$300,000 of INVESCO HOLDING COMPANY (US) INC lobbying was just disclosed, from Q2 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Issues related to investment management regulation, including exchange-traded funds, mutual funds, money market funds and proxy voting. SEC ESG Rules. SEC Predictive Analytics Rule. CFTC Rule 1.25. Retirement and savings reform. Retirement Fairness for Charities and Educational Institutions Act (H.R. 3063/S.4917) and Increasing Investor Opportunities Act (H.R. 2627). Tax Policy (H.R. 1)."
You can find more data on corporate lobbying on Quiver Quantitative.
IVZ Congressional Stock Trading
Members of Congress have traded $IVZ stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $IVZ stock by members of Congress over the last 6 months:
- REPRESENTATIVE ROBERT BRESNAHAN sold up to $15,000 on 04/08.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
IVZ Hedge Fund Activity
We have seen 250 institutional investors add shares of IVZ stock to their portfolio, and 260 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 7,058,893 shares (-12.8%) from their portfolio in Q1 2025, for an estimated $107,083,406
- MILLENNIUM MANAGEMENT LLC removed 4,582,311 shares (-63.3%) from their portfolio in Q1 2025, for an estimated $69,513,657
- GOLDMAN SACHS GROUP INC added 3,507,150 shares (+99.6%) to their portfolio in Q1 2025, for an estimated $53,203,465
- BALYASNY ASSET MANAGEMENT L.P. added 3,220,523 shares (+inf%) to their portfolio in Q1 2025, for an estimated $48,855,333
- AQR CAPITAL MANAGEMENT LLC added 2,882,928 shares (+35.4%) to their portfolio in Q1 2025, for an estimated $43,734,017
- UBS GROUP AG added 2,495,254 shares (+68.7%) to their portfolio in Q1 2025, for an estimated $37,853,003
- MARSHALL WACE, LLP added 2,439,846 shares (+1891.8%) to their portfolio in Q1 2025, for an estimated $37,012,463
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
IVZ Analyst Ratings
Wall Street analysts have issued reports on $IVZ in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Argus Research issued a "Buy" rating on 01/29/2025
To track analyst ratings and price targets for IVZ, check out Quiver Quantitative's $IVZ forecast page.
IVZ Price Targets
Multiple analysts have issued price targets for $IVZ recently. We have seen 15 analysts offer price targets for $IVZ in the last 6 months, with a median target of $17.0.
Here are some recent targets:
- Benjamin Budish from Barclays set a target price of $17.0 on 07/16/2025
- Michael Brown from Wells Fargo set a target price of $18.0 on 07/11/2025
- Arun Viswanathan from RBC Capital set a target price of $16.0 on 07/10/2025
- Michael Cyprys from Morgan Stanley set a target price of $16.0 on 07/02/2025
- Alexander Blostein from Goldman Sachs set a target price of $16.75 on 06/27/2025
- Glenn Schorr from Evercore ISI Group set a target price of $15.0 on 04/23/2025
- Kenneth Worthington from JP Morgan set a target price of $16.0 on 04/16/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
